Blaine Davis
CIK 1802188 · Chief Financial Officer · last filed 2026-01-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.23M
Companies
3
Total Filings
12
Lifetime Open-Market Net
-$181.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNAC | Chief Financial Officer | 121,220 | $9.51 | $1.15M | -$206.3K | 6 | 2026-01-08 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Chief Financial Officer | — | $0.88 | — | $0 | 1 | 2022-11-30 |
| TARA | Chief Financial Officer | 20,662 | $3.90 | $80.6K | $25.0K | 5 | 2022-07-19 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-23 | TARA | Buy (P) | +1,481 | $25.0K | EDGAR |
| 2020-02-11 | TARA | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.